Table 2.
Naringin and Mets | Mechanism of Action | Outcome |
---|---|---|
Effect on visceral obesity | (i) Increases the intracellular calcium which increases the protein associated with cell death (calpain & caspase-12) | Leads to adipocyte apoptosis and reduce obesity |
| ||
Effect on hypertension | (i) Suppresses the increased level of nitric oxide (NO) (ii) Radical scavenging ability of naringin increased SOD |
Leads to failure in smooth muscle relaxation resulting in lower blood pressure |
| ||
Effect on hyperglycemia | (i) Reduced the level of HbA1C and FBG (ii) Increased the level of insulin through proliferation of pancreatic β cells. (iii) Increased the hepatic and muscle glycogen content by lowering the activities of G6Pase and PEPCK. |
Leads to reduction in circulating blood glucose |
| ||
Effect on hyperlipidemia | (i) Reduced LDL levels by reducing VLDL and increasing the depuration of LDL receptors. (ii) Increased the levels of HDL due to inhibition of rho-signalling pathways with activation of PPAR-α and CETP. (iii) Inhibited the activity of HMG-CoA reductase that suppresses the cholesterol homeostasis. (iv) Reduced the ACAT activity by interacting with residues that play essential role in enzyme catalysis. |
Leads to reduction in the lipid profiles and cholesterol biosynthesis |
| ||
Effect on oxidative stress | (i) Naringin as a strong radical scavenger prevented the lipid peroxidation by trapping the free radicals through the donation of hydrogen atom and breaking the chain reaction. | Leads to prevention of the radicals attack on lipids, amino acid, fatty acids and DNA bases. |
| ||
Effect on proinflammatory cytokines | (i) Reduced the levels of resistin and increased levels of adiponectin by suppressing the biological activity and production of the cytokines. | Leads to prevention of obesity, insulin resistance and lipid abnormalities |